The aims of this narrative review are to discuss such evidence, often feeble, in the setting of laryngeal squamous cell carcinomas, and to put the attention front and center on p16INK4a, which is often a misunderstood marker that is discussed prevalently in relation to HPV in this particular setting. This evidence concerns the gene CDKN2A and laryngeal squamous cell carcinoma.